In addition, ACE2–deficient mice suffered more aggravated lung injury compared with wild–type mice in models of ARDS, whereas therapy with recombinant ACE2 improved ARDS in Ace2–knockout, especially in wild–type mice14. Here, ACE2 is linked to acute respiratory distress syndrome.